After a large influx of institutional funds into Bitcoin, a new wave of 'Binance Coin (BNB) holding' strategies has emerged among listed companies.

Through the issuance of convertible bonds or direct purchases, companies are starting to hold Binance Coin as a reserve asset to enhance reserve yield, improve liquidity, and gain strategic access to the crypto ecosystem.

According to CZ, at least 30 teams are actively exploring this strategy, and here are several publicly announced examples: YZi Labs with 10X Capital: CZ's family office (formerly Binance Labs) supports 10X Capital in establishing a new company, planning to go public in the U.S. stock market, focusing on BNB reserves.

The CEO is David Namdar, co-founder of Galaxy Digital, highlighting Wall Street endorsement. Nano Labs: A Nasdaq chip company plans to invest $1 billion ($500 million convertible bonds), has purchased 120,000 BNB ($90 million, average price $672), targeting to hold 5-10% of the circulating supply.

Windtree Therapeutics: A Nasdaq biotech company, secured a $720 million financing commitment, most of which is for BNB reserves.

The formation of reserve assets creates a value flywheel: Public companies buy BNB → Price increases → Asset value rises → More BNB financing. In summary, fundamentals: Strong cash flow, ecological scale, compliance. Liquidity: High trading volume, global market recognition. Functionality: Multi-scenario applications (payments, staking, governance).

BNB is transforming from an exchange token to an institutional-grade reserve asset, accompanied by a long bull market in the second half of the year, potentially doubling or tripling by the end of the year.

😆$BNB